A new study confirms that preoperative pelvic radiation, with or without concurrent chemotherapy, is safe and effective in IBD patients with locally advanced rectal cancer.
Learn how Cleveland Clinic is advancing gastrointestinal care: Examining the link between IBD and liver disease, predicting progression in Barrett’s esophagus and investigating stem cell therapy for Crohn’s disease.
Inflammatory bowel disease patients who undergo ileal pouch-anal anastomosis and whose pouch survives several years without complication are likely to have excellent long-term outcomes, a Cleveland Clinic conditional survival study has found.
The presence of inflammatory bowel disease conveys increased risk of comorbid nonalcoholic fatty liver disease, nonalcoholic steatohepatitis and nonalcoholic cirrhosis, two new Cleveland Clinic epidemiological studies show.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Miguel Regueiro, MD, Chair of Cleveland Clinic’s Department of Gastroenterology, Hepatology and Nutrition, highlights six can’t-miss DDW presentations by our researchers.
If you’re looking for the latest insights and leading-edge information on IBD and gastrointestinal endoscopy, you’ll want to attend these upcoming Cleveland Clinic CME events.
Cleveland Clinic colorectal surgeon Amy Lightner, MD, a leading translational researcher and clinical trials director, talks about stem cells’ potential to improve IBD management.
Miguel Regueiro, MD, the recently appointed chair of Cleveland Clinic’s Gastroenterology, Hepatology and Nutrition Department, shares some thoughts on patient care, leadership and the future of healthcare.
Fragmentation of care is a common problem across many gastrointestinal conditions. Learn about three focused programs Cleveland Clinic has developed for complex GI cases.
The integrated health approach delivered in the scope of IBD medical home reaches beyond the biological disease and captures 90 percent or more of the patient’s needs, whereas the standard approach that involves only a gastroenterologist has proven to only focus on the disease itself. GI Chairman Miguel Regueiro explains.